| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 666.2 | 721.5 | 558.8 |
| Other income | 15.2 | 4.2 | 9.0 |
| Total income | 681.4 | 725.7 | 567.8 |
| Profit before exceptional items & tax | 113.4 | 129.7 | 81.2 |
| Profit before tax | 113.4 | 129.7 | 81.2 |
| Net profit | 82.8 | 94.1 | 57.6 |
| Operating margin | 16.6% | 17.9% | 14.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +43.70% |
|---|---|
| Net profit, quarter on quarter | -12.00% |
| Revenue, year on year | +19.20% |
| Operating profit, year on year | +39.10% |
| Operating profit, quarter on quarter | -24.80% |
NSE results filing, NSE: PRIVISCL. Figures extracted from the filing.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,594.10
- Market cap
- ₹14,040 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 40.1×Sector 37.5×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 1.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Capital Structure Change
SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals announced an NCLT-convened meeting of equity shareholders for October 27, 2026, to consider the proposed Scheme of Amalgamation involving two transferor companies.
Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways
Privi reports 19.22% revenue growth and steady 24% EBITDA margins. Management maintains a confident outlook on expansion despite gross margin compression from high raw material costs compared to last year's low-cost base.
- Call
- Guides 100% growth
Privi Speciality Chemicals Investor Presentation: Key Takeaways
Privi reported strong Q1 FY27 results with 20.01% YoY revenue growth. Strategy focuses on '5k | 1k' vision via capacity expansion and higher-value specialty molecules.
- Call
- Guides 100% growth
Privi Speciality Chemicals Earnings Call: Key Takeaways
Privi reported strong FY26 performance with 22% revenue growth and 25.76% EBITDA margins, driven by volume growth and improved product mix.
Privi Speciality Chemicals Earnings Call: Key Takeaways
Privi delivered strong FY26 performance with 22% revenue growth and 25%+ margins. Management is pivoting from a '5k revenue' goal to a more aggressive long-term trajectory via high-value specialty molecules and backward integration.